Prince Talal Honors 2026 King Hussein Cancer Research Award Winners on Behalf of King Abdullah II

Prince Talal Honors 2026 King Hussein Cancer Research Award Winners on Behalf of King Abdullah II

Amman, Jordan – November 14, 2026 – Deputizing for His Majesty King Abdullah II, HRH Prince Talal bin Muhammad honored the recipients of the 2026 King Hussein Cancer Research Award during a ceremony celebrating the achievements of Arab scientists and researchers whose contributions continue to advance cancer research and treatment.

The ceremony was held in the presence of HRH Princess Ghida Talal, Chairperson of the King Hussein Cancer Foundation (KHCF) and King Hussein Cancer Center (KHCC), alongside members of the Royal Family, senior officials, and distinguished representatives of the international oncology community.

The annual award recognizes outstanding contributions to cancer research, supports scientific efforts to improve cancer prevention and treatment, and promotes collaboration among researchers at regional and international levels.

This year’s recipients were selected from hundreds of applicants representing more than 26 countries, reflecting the growing contributions of Arab scientists to oncology research worldwide.

Prince Talal

Celebrating Arab Scientific Excellence

Addressing attendees during the ceremony, Princess Ghida Talal emphasized the importance of recognizing scientific achievements originating from the Arab world and their potential to improve outcomes for cancer patients.

“Tonight, we come together to honor and celebrate the winners of the King Hussein Cancer Research Award — Arab scientists who demonstrate that discovery can begin right here, in the Arab world, and for the sake of our patients.”

Her remarks reflected the award’s central mission: to recognize scientific achievement while encouraging Arab researchers to pursue discoveries that can contribute to better cancer care.

Prince Talal

Recognizing Leaders in Cancer Research

Among the distinguished recipients, Prof. Nizar Tannir of The University of Texas MD Anderson Cancer Center received the Award for Excellence in Cancer Research in recognition of his outstanding achievements in kidney cancer research and treatment.

The Lifetime Achievement Award – International Track was presented to Prof. Amer Zeidan of Yale Cancer Center, recognizing his contributions to the field of oncology.

Meanwhile, Prof. Imam Waked of Menoufia University received the Lifetime Achievement Award – Regional Track, acknowledging his longstanding contributions to cancer research.

These distinctions recognize researchers whose scientific careers have contributed to the advancement of oncology and the development of cancer care.

Prince Talal

Honoring the Next Generation of Cancer Researchers

The ceremony also recognized emerging scientific leaders whose work represents the future of cancer research.

Dr. Myriam Chalabi of the Netherlands Cancer Institute received the Young Investigator Award – International Track, while Prof. Omneya Attallah of the Arab Academy for Science, Technology and Maritime Transport was honored with the Young Investigator Award – Regional Track.

Through these awards, the King Hussein Cancer Research Award continues to encourage early-career researchers and support the development of scientific talent across the Arab world and internationally.

Prince Talal

Supporting Research Through New Grants

Beyond recognizing established scientific achievements, the award also provides financial support for upcoming cancer research projects.

The Promising Researcher Grant was awarded to two researchers:

  • Dr. Zaid Abdel-Rahman, King Hussein Cancer Center
  • Dr. Philippe Kobeissy, Lebanese American University

The grants will support their upcoming cancer research projects, reinforcing the award’s commitment to encouraging new scientific investigations and supporting researchers in developing their work.

Prince Talal

Recognizing Excellence in Bone Marrow Transplantation

The Professional Development Program for Cancer Care Excellence was awarded to the Bone Marrow and Stem Cell Transplantation Program at King Hussein Cancer Center.

The program performs more than 200 bone marrow transplants annually, with reported success rates exceeding 75%.

The recognition highlights the importance of specialized clinical programs in cancer care and acknowledges the contributions of multidisciplinary medical teams to the treatment of patients requiring bone marrow and stem cell transplantation.

Prince Talal

A Lasting Legacy in Arab Cancer Research

Established in 2020 in memory of His Majesty the late King Hussein bin Talal, the King Hussein Cancer Research Award has become one of the most prestigious scientific distinctions in cancer research across the Arab world.

The award was founded to encourage Arab scientists and researchers worldwide to pursue advances in cancer prevention, diagnosis, and treatment, while strengthening scientific cooperation and supporting research that addresses the needs of cancer patients.

Since its establishment, the initiative has contributed to the development of an increasingly connected Arab cancer research community.

Over the past five years, the award has received more than 950 applications from over 30 countries, with submissions evaluated by more than 15 international experts in cancer research and oncology.

These figures reflect the award’s expanding international reach and the participation of researchers working across different areas of cancer science.

Prince Talal

Bringing the Oncology Community Together in Amman

The 2026 ceremony brought together several ministers, members of the Award’s Board of Directors, leading oncologists, physicians, researchers, prominent academic and media figures, and the award’s partners and supporters.

The gathering provided an opportunity to recognize scientific accomplishments while emphasizing the importance of continued investment in cancer research and international collaboration.

Prince Talal

By honoring established investigators, supporting promising researchers, and recognizing excellence in clinical care, the King Hussein Cancer Research Award continues to strengthen the role of Arab scientists in global oncology.

The 2026 recipients represent different generations, institutions, and areas of cancer research, united by a shared commitment to advancing scientific knowledge and improving care for patients with cancer.

More articles like this are available on OncoDaily

Vahe Grigoryan
Fact checked by Vahe Grigoryan MD, Editorial Director
Vahe Grigoryan
Medically reviewed by Vahe Grigoryan MD, Editorial Director